SCHEMBL875667

SCHEMBL875667

CCNc1cc(-c2ccc(N)cc2)sc1C(=O)NCCN1CCS(=O)(=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 2/20 0.42
MAP3K7 O43318 1/20 0.39
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCN9A Q15858 1/20 0.37
JAK2 O60674 2/20 0.36
JAK1 P23458 2/20 0.36
TYK2 P29597 2/20 0.36
JAK3 P52333 2/20 0.36
MMP2 P08253 1/20 0.35
MMP8 P22894 1/20 0.35
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
TGFBR1 P36897 2/20 0.35
BMPR1B O00238 1/20 0.35
BMPR1A P36894 1/20 0.35
ACVRL1 P37023 1/20 0.35
ACVR1 Q04771 1/20 0.35
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875170 0.82 HDAC1 (0.41) MAP3K7JAK2JAK1TYK2JAK3
SCHEMBL10069158 0.80 CD274 (0.41) CD274USP2SCN9AACVR1HDAC2
SCHEMBL874666 0.76 IKBKB (0.55) SMN1; SMN2JAK2JAK1TYK2JAK3
SCHEMBL10070169 0.73 NAMPT (0.36) CD274MAP3K7JAK2JAK1TYK2
SCHEMBL875205 0.73 PTPN1 (0.51) SMN1; SMN2ALDH1A1KMT2AMAPTHSD17B10
SCHEMBL875381 0.72 NAMPT (0.47) JAK2JAK1TYK2JAK3KMT2A
SCHEMBL882720 0.71 KDM4E (0.53) SMN1; SMN2ALDH1A1KMT2AMAPTHSD17B10
SCHEMBL882758 0.67 CD274 (0.37) CD274SCN9AALDH1A1TSHRCYP1A2
SCHEMBL28735456 0.64 MEN1 (0.49) CD274TGFBR1HDAC2HDAC8HDAC6
SCHEMBL13071736 0.63 CHRNB2 (0.57) CD274SCN9AHDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed